BROCCA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 5.144
AS - Asia 2.784
EU - Europa 987
AF - Africa 428
SA - Sud America 405
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 13
Totale 9.818
Nazione #
US - Stati Uniti d'America 4.926
SG - Singapore 807
CN - Cina 517
VN - Vietnam 497
HK - Hong Kong 344
BR - Brasile 242
IT - Italia 157
DE - Germania 112
IN - India 81
GB - Regno Unito 75
FR - Francia 64
JP - Giappone 63
FI - Finlandia 61
SE - Svezia 61
PL - Polonia 59
AR - Argentina 44
NL - Olanda 41
TR - Turchia 37
IQ - Iraq 36
RU - Federazione Russa 31
IE - Irlanda 30
BD - Bangladesh 27
MX - Messico 27
CA - Canada 25
ZA - Sudafrica 25
ID - Indonesia 24
CL - Cile 22
PK - Pakistan 22
AE - Emirati Arabi Uniti 21
CI - Costa d'Avorio 21
EC - Ecuador 21
ES - Italia 21
PH - Filippine 20
UA - Ucraina 18
DO - Repubblica Dominicana 17
EG - Egitto 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
KR - Corea 16
MY - Malesia 16
AO - Angola 15
AZ - Azerbaigian 15
CR - Costa Rica 15
GR - Grecia 15
MR - Mauritania 15
RW - Ruanda 15
ET - Etiopia 14
MG - Madagascar 14
MU - Mauritius 14
NC - Nuova Caledonia 14
NP - Nepal 14
TH - Thailandia 14
TN - Tunisia 14
UG - Uganda 14
VE - Venezuela 14
CD - Congo 13
HN - Honduras 13
JM - Giamaica 13
LB - Libano 13
AU - Australia 12
BZ - Belize 12
CO - Colombia 12
CY - Cipro 12
DK - Danimarca 12
GT - Guatemala 12
HU - Ungheria 12
KE - Kenya 12
MA - Marocco 12
NZ - Nuova Zelanda 12
PT - Portogallo 12
AL - Albania 11
AT - Austria 11
BE - Belgio 11
BJ - Benin 11
CG - Congo 11
GE - Georgia 11
IL - Israele 11
IR - Iran 11
IS - Islanda 11
LV - Lettonia 11
MD - Moldavia 11
ML - Mali 11
PE - Perù 11
PY - Paraguay 11
SK - Slovacchia (Repubblica Slovacca) 11
ZM - Zambia 11
AF - Afghanistan, Repubblica islamica di 10
GF - Guiana Francese 10
KG - Kirghizistan 10
LC - Santa Lucia 10
MK - Macedonia 10
SI - Slovenia 10
SO - Somalia 10
UY - Uruguay 10
ZW - Zimbabwe 10
AM - Armenia 9
BF - Burkina Faso 9
BS - Bahamas 9
BW - Botswana 9
Totale 9.397
Città #
Fairfield 763
Ashburn 529
Singapore 521
San Jose 435
Woodbridge 353
Houston 329
Hong Kong 296
Seattle 273
Cambridge 247
Chandler 246
Wilmington 227
Ann Arbor 214
Hanoi 152
Ho Chi Minh City 149
Santa Clara 114
Beijing 113
Los Angeles 93
San Diego 64
Boardman 58
Munich 55
Des Moines 47
Medford 47
New York 47
Princeton 45
Lauterbourg 44
Tokyo 42
Bytom 39
Da Nang 32
Helsinki 30
São Paulo 29
Padova 26
Dublin 25
Nanjing 23
Council Bluffs 22
Milan 22
Abidjan 21
London 21
Orem 21
Roxbury 21
Dallas 20
Guangzhou 19
Buffalo 18
Chicago 18
Jinan 18
Turku 17
Shanghai 16
Haiphong 15
Kigali 15
Dong Ket 14
Luanda 14
Noumea 14
Shenyang 14
Tashkent 14
Antananarivo 13
Baku 13
Frankfurt am Main 13
Kampala 13
Nouakchott 13
Warsaw 13
Chennai 12
Denver 12
Atlanta 11
Bamako 11
Cotonou 11
Lusaka 11
Nanchang 11
Riga 11
San José 11
Stockholm 11
Addis Ababa 10
Baghdad 10
Castries 10
Istanbul 10
Kinshasa 10
Athens 9
Auckland 9
Brooklyn 9
Conakry 9
Dubai 9
Dushanbe 9
Hebei 9
Nassau 9
Phnom Penh 9
San Francisco 9
Tbilisi 9
Tianjin 9
Ulan Bator 9
Amman 8
Bishkek 8
Bến Tre 8
Cape Town 8
Cayenne 8
Changsha 8
Chisinau 8
Curitiba 8
Erbil 8
Harare 8
Hefei 8
Hải Dương 8
Kingston 8
Totale 6.522
Nome #
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 354
Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis 345
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 323
Effect of percutaneous ventricular assist devices on renal function 289
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 287
Thoughts modulate the expression of inflammatory genes and may improve the coronary blood flow in patients after a myocardial infarction 275
Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways 270
Optimizing a kidney stress test to evaluate renal functional reserve 269
Pro-Apoptotic Effects of Plasma from Patients with Cardiorenal Syndrome on Human Tubular Cells 238
Infections complicating cirrhosis 237
Elevated Levels of Procalcitonin and Interleukin-6 are Linked with Postoperative Complications in Cardiac Surgery 228
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 225
A comparison of three commercial platforms for urinary NGAL in critically ill adults 223
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 220
The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1 219
Delayed Nephrology Consultation and High Mortality on Acute Kidney Injury: A Meta-Analysis 213
Procalcitonin and Interleukin-6 Levels: Are They Useful Biomarkers in Cardiac Surgery Patients? 212
High cut-off hemofiltration versus standard hemofiltration: A pilot assessment of effects on indices of apoptosis 211
Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature 210
Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile 207
Advances in the pathogenesis of cardiorenal syndrome type 3 205
In-vitro Evaluation of proBPN Extracorporeal Removal during Hemodialysis with High Cut-Off Membrane 204
Oxidative stress: Dual pathway induction in cardiorenal syndrome type 1 pathogenesis 200
In vitro Cytotoxicity of Bisphenol A in Monocytes Cell Line 200
Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment 195
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event 194
The role of cell-free plasma DNA in peritoneal dialysis patients with peritonitis 193
Cardiorenal syndrome type 1: A defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors 193
Fabry’s disease: an example of cardiorenal syndrome type 5 191
The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5 189
In-vitro Evaluation of NGAL Extracorporeal Removal during Hemodialysis with High Cut-Off Membrane 186
The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis 186
Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats 184
Characterization of molecular pathways involved in acute and acute-on-chronic liver disease 183
Renal Function in Cirrhosis: A Critical Review of Available Tools 181
Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes 179
Molecular and Genetic Mechanisms Involved in the Pathogenesis of Cardiorenal Cross Talk 177
Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation 176
Brief Review and a Clinical Case of Hemolytic Uremic Syndrome Associated with Interferon β Treatment 176
Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes 175
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury 172
Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis 169
Rationale for the Evaluation of Renal Functional Reserve in Living Kidney Donors and Recipients: A Pilot Study 167
Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography 163
Pro-inflammatory cytokines: A possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients 143
Cardio-pulmonary-renal interactions: A multidisciplinary approach 142
Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation 122
Totale 9.900
Categoria #
all - tutte 27.122
article - articoli 26.482
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021180 0 0 0 0 0 0 0 0 0 0 107 73
2021/2022673 37 60 94 55 27 37 39 72 32 17 58 145
2022/2023502 97 65 4 66 65 57 9 41 69 1 19 9
2023/2024258 12 24 43 27 15 20 28 21 5 10 33 20
2024/20251.170 7 100 47 68 151 37 53 94 69 55 198 291
2025/20264.666 213 386 617 704 436 185 889 385 474 263 114 0
Totale 9.900